Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?

International Journal of Environmental Research and Public Health

Volumn 8, Issue 10, 2011, Pages 3889-3921

  Kisby, Glen E ^a   Spencer, Peter S ^b  

^a Western University of Health Sciences   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Amyotrophic lateral sclerosis (ALS); Cycad; Dna damage; Formaldehyde; Guam; Methylazoxymethanol (MAM); Neurodegenerative disease; Nitrosamines; Parkinsonism dementia; Tauopathy; n methylamino l alanine (L BMAA)

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; GENOTOXIN; METHYLAZOXYMETHANOL GLUCOSIDE; NEUROTOXIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHEMICAL STRUCTURE; CYCAD; DEGENERATIVE DISEASE; DEMENTIA; HUMAN; MEDICINAL PLANT; NEUROBIOLOGY; PARKINSONISM; PATHOGENESIS; PATHOPHYSIOLOGY; TAUOPATHY;

CYCADOPSIDA;

EID: 80055119734     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph8103889     Document Type: Article

References (148)

1. Spencer, P.S. Guam ALS/Parkinsonism-dementia: A long-latency neurotoxic disorder caused by 'slow toxin(s)' in food? Can. J. Neurol. Sci. 1987, 14, 347-357.
2. Spencer, P.S.; Kisby, G.E.; Ludolph, A.C. Slow toxins, biologic markers, and long-latency neurodegenerative disease in the western Pacific region. Neurology 1991, 41, 62-66.
3. McGeer, P.L.; Steele, J.C. The ALS/PDC syndrome of Guam: Potential biomarkers for anenigmatic disorder. Prog. Neurobiol. 2011, In press.
4. Winton, M.J.; Joyce, S.; Zhukareva, V.; Practico, D.; Perl, D.P.; Galasko, D.; Craig, U.; Trojanowski, J.Q.; Lee, V.M. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex. Acta Neuropathol. 2006, 111, 401-412.
5. Waring, S.C.; Esteban-Santillan, C.; Reed, D.M.; Craig, U.K.; Labarthe, D.R.; Petersen, R.C.; Kurland, L.T. Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989. Neuroepidemiology 2004, 23, 192-200.
6. Kuzuhara, S.; Kokubo, Y. Atypical parkinsonism of Japan: Amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease): An update. Mov. Disord. 2005, 20, S108-S113.
7. Mimuro, M.; Kokubo, Y.; Kuzuhara, S. Similar topographical distribution of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia complex in people living in the Kii peninsula of Japan suggests a single tauopathy. Acta Neuropathol. 2007, 113, 653-658.
8. Gajdusek, D.C.; Salazar, A.M. Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea. Neurology 1982, 32, 107-126.
9. Spencer, P.S.; Palmer, V.S.; Ludolph, A.C. On the decline and etiology of high incidence motor system disease in West Papua (southwest New Guinea). Mov. Disord. 2005, 20, 119-126.
10. Gajdusek, D.C.; Zigas, V. Kuru; clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the Eastern Highlands of New Guinea. Am. J. Med. 1959, 26, 442-469.
11. Norrby, E. Prions and protein-folding diseases. J. Intern. Med. 270, 1-14.
12. Galasko, D.; Salmon, D.P.; Craig, U.K.; Thal, L.J.; Schellenberg, G.; Wiederholt, W. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology 2002, 58, 90-97.
13. Sundar, P.D.; Yu, C.E.; Sieh, W.; Steinbart, E.; Garruto, R.M.; Oyanagi, K.; Craig, U.-K.; Bird, T.D.; Wijsman, E.M.; Galasko, D.R.; Schellenberg, G.D. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum. Mol. Genet. 2007, 16, 295-306.
14. Tomiyama, H.; Kokubo, Y.; Sasaki, R. Li, Y.; Imamichi, Y.; Funayama, M.; Mizuno, Y.; Hattori, N.; Kuzuhara, S. Mutation analyses in amyotrophic lateral sclerosis/parkinsonismdementia complex of the Kii peninsula, Japan. Mov. Disord. 2008, 23, 2344-2348.
15. Hermosura, M.C.; Garruto, R.M. TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD? Biochim. Biophys. Acta 2007, 1772, 822-835.
16. Hermosura, M.C.; Nayakanti, H.; Dorovkov, M.V.; Calderon, F.R.; Ryazanov, A.G.; Haymer, D.S.; Garruto, R.M. A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders. Proc. Natl. Acad. Sci. USA 2005, 102, 11510-11515.
17. Hara, K.; Kokubo, Y.; Ishiura, H.; Fukuda, Y.; Miyashita, A.; Kuwano, R.; Sasaki, R.; Goto, J.; Nishizawa, M.; Kuzuhara, S.; Tsuji, S. TRPM7 is not associated with amyotrophic lateral sclerosis-parkinsonism dementia complex in the Kii peninsula of Japan. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B, 310-313.
18. Kurland, L.T. An appraisal of the neurotoxicity of cycad and the etiology of amyotrophic lateral sclerosis on Guam. Fed. Proc. 1972, 31, 1540-1542.
19. Oyanagi, K.; Kawakami, E.; Kikuchi-Horie, K.; Ohara, K.; Ogata, K.; Takahama, S.; Wada, M.; Kihira, T.; Yasui, M. Magnesium deficiency over generations in rats with special references to the pathogenesis of the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Neuropathology 2006, 26, 115-128.
20. Ahlskog, J.E.; Waring, S.C.; Kurland, L.T.; Petersen, R.C.; Moyer, T.P.; Harmsen, W.S.; Maraganore, D.M.; O'Brien, P.C.; Esteban-Santillan, C.; Bush, V. Guamanian neurodegenerative disease: Investigation of the calcium metabolism/heavy metal hypothesis. Neurology 1995, 45, 1340-1344.
21. Whiting, M. Identification of toxic elements of cycads. In Toxicity of Cycads; Implications for Neurodegenerative Diseases and Cancer, Transcripts of the Four Cycad Conferences; Third World Medical Research Foundation: 1988, New York, NY, USA.
22. Bell, E.A.; Vega, A.; Nunn, P.B. A neurotoxic amino acid in seeds of cycas circinalis. In Toxicity of Cycads; Implications for Neurodegenerative Diseases and Cancer, Transcripts of the Four Cycad Conferences; Third World Medical Research Foundation:1988, New York, NY, USA.
23. Spencer, P.S.; Nunn, P.B.; Hugon, J.; Ludolph, A.C.; Ross, S.M.; Roy, D.N.; Robertson, R.C. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 1987, 237, 517-522.
24. Banack, S.A.; Cox, P.A. Biomagnification of cycad neurotoxins in flying foxes: Implications for ALS-PDC in Guam. Neurology 2003, 61, 387-389.
25. Spencer, P.S.; Palmer, V.; Herman, A.; Asmedi, A. Cycad use and motor neuron disease in Irian Jaya. Lancet 1987, 2, 1273-1274.
26. Spencer, P.S.; Ohta, M.; Palmer, V. Cycad use and motor neuron disease in Kii peninsula of Japan. Lancet 1987, 2, 1462-1463.
27. Kobayashi, A. Cycasin in cycad materials used in Japan. Fed. Proc. 1972, 31, 1476 1477.
28. Kisby, G.E.; Ellison, M.; Spencer, P.S. Content of the neurotoxins cycasin (methylazoxymethanol β-D-glucoside) and BMAA (β-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros. Neurology 1992, 42, 1336-1340.
29. Zegura, B.; Straser, A.; Filipic, M. Genotoxicity and potential carcinogenicity of cyanobacterial toxins - a review. Mutat. Res. 2011,727, 16-41.
30. Ross, S.M.; Seelig, M.; Spencer, P.S. Specific antagonism of excitotoxic action of 'uncommon' amino acids assayed in organotypic mouse cortical cultures. Brain Res. 1987, 425, 120-127.
31. Allen, C.N.; Omelchenko, I.; Ross, S.M.; Spencer, P. The neurotoxin, beta-N methylamino-Lalanine (BMAA) interacts with the strychnine-insensitive glycine modulatory site of the N-methyl-D-aspartate receptor. Neuropharmacology 1995, 34, 651-658.
32. Weiss, J.H.; Koh, J.-Y.; Choi, D.W. Neurotoxicity of β-N-methylamino-L-alanine (BMAA) and β-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons. Brain Res. 1989, 497, 64-71.
33. Weiss, J.H.; Choi, D.W. β-N-Methylamino-L-alanine neurotoxicity: Requirement for bicarbonate as a cofactor. Science 1994, 19, 973-975.
34. Ross, S.M.; Spencer, P.S. Specific antagonism of behavioral action of 'uncommon' amino acids linked to motor-system diseases. Synapse 1987, 1, 248-253.
35. Spencer, P.S.; Hugon, J.; Ludolph, A.; Nunn, P.B.; Ross, S.M.; Roy, D.N.; Schaumburg, H.H. Discovery and partial characterization of primate motor-system toxins. Ciba Found. Symp. 1987, 126, 221-238.
36. Costa, L.G.; Giordano, G.; Faustman, E.M. Domoic acid as a developmental neurotoxin. Neurotoxicology, 2010, 31, 409-423.
37. Teitelbaum, J.S.; Zatorre, R.J.; Carpenter, S.; Gendron, D.; Evans, A.C.; Gjedde, A.; Cashman, N.R. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N. Engl. J. Med. 1990, 322, 1781-1787.
38. Banack, S.A.; Murch, S.J.; Cox, P.A. Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J. Ethnopharmacol. 2006, 106, 97-104.
39. Murch, S.J.; Cox, P.A.; Banack, S.A.; Steele, J.C.; Sacks, O.W. Occurrence of beta-methylaminol-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol. Scand. 2004, 110, 267-269.
40. Kisby, G.E.; Ross, S.M.; Spencer, P.S.; Gold, B.G.; Nunn, P.B.; Roy, D.N. Cycasin and BMAA: Candidate neurotoxins for western Pacific amyotrophic lateral sclerosis/Parkinsonism-dementia complex. Neurodegeneration 1992, 1, 73-82.
41. Spencer, P.S.; Ross, S.M.; Kisby, G.; Roy, D.N. Western Pacific amyotrophic lateral sclerosis: putative role of cycad toxins. In Amyotrophic Lateral Sclerosis: Concepts in Pathogenesis and Etiology, Hudson, A.J., Ed.; University of Toronto Press: Toronto, ON, Canada,1990; pp. 263-295.
42. Nunn, P.B.; Ponnusamy, M. Beta-N-methylaminoalanine (BMAA): Metabolism and metabolic effects in model systems and in neural and other tissues of the rat in vitro. Toxicon 2009, 54, 85-94.
43. Kisby, G.E.; Nottingham, V.; Kayton, R.; Roy, D.N.; Spencer, P.S. Brain metabolism of β-N-methylamino-L-alanine (BMAA) and protection of excitotoxicity by GABA-uptake inhibitors. Soc. Neurosci. 1992, 18, 82.
44. Ravindranath, V.; Ananda Theertha Varada, H.K. High activity of cytochrome P-450-linked aminopyrine N-demethylase in mouse brain microsomes, and associated sex-related difference. Biochem. J. 1989, 261, 769-773.
45. Kisby, G.E.; Roy, D.N.; Spencer, P.S. Determination of β-N-methylamino-L-alanine (BMAA) in plant (Cycas circinalis L.) an animal tissue by precolumn derivatization with 9-fluorenylmethyl chloroformate (FMOC) and reversed-phase high-performance liquid chromotography. J. Neurosci. Methods 1988, 26, 45-54.
46. Pai, K.S.; Ravindranath, V. Protection and potentiation of MPTP-induced toxicity by cytochrome P-450 inhibitors and inducer: In vitro studies with brain slices. Brain Res. 1991, 555, 239-244.
47. Pickard, M.R.; Sinha, A.K.; Gullo, D.; Patel, N.; Hubank, M.; Ekins, R.P. The effect of 3,5,3'-triiodothyronine on leucine uptake and incorporation into protein in cultured neurons and subcellular fractions of rat central nervous system. Endocrinology 1987, 121, 2018-2026.
48. Kisby, G.E.; Kabel, H.; Hugon, J.; Spencer, P. Damage and repair of nerve cell DNA in toxic stress. Drug Metab. Rev. 1999, 31, 589-618.
49. Zhang, Z.X.; Anderson, D.W.; Mantel, N.; Román, G.C. Motor neuron disease on Guam: Geographic and familial occurrence, 1956-85. Acta Neurol. Scand. 1996, 94, 51-59.
50. Roman, G.C.; Zhang, Z.-X.; Ellenberg, J.A. The Neuroepidemiology of Parkinson's Disease; Marcel Dekker: 1995, New York, NY, USA.
51. Spencer, P.S.; Dastur, D.K. Neurolathyrism and neurocycadism. In Neurological Sciences-An Overview of Current Problems Section VI Tropical Neurology and NeurotoxicologyI; Dastur, D.K., Shahani, M., Bharucha, E.P., Eds.; Interprint: New Delhi, India, 1986; Section VI.
52. Spencer, P.S.; Kisby, G.E.; Palmer, V.S.; Obendorf, P. Cycasin, Methylazoxymethanol, and related compounds. In Experimental and Clinical Neurotoxicology, 2nd ed.; Spencer, P.S., Schaumburg, H.H., Eds.; Oxford University Press: New York, NY, USA, 1999; pp. 436-447.
53. Sieber, S.M.; Correa, P.; Dalgard, D.W.; McIntire, K.R.; Adamson, R.H. Carcinogenicity and hepatotoxicity of cycasin and its aglycone methylazoxymethanol acetate in nonhuman primates. J. Natl. Cancer Inst. 1980, 65, 177-189.
54. Adamson, R.H. Induction of hepatocellular carcinoma in nonhuman primates by chemical carcinogens. Cancer Detect. Prev. 1989, 14, 215-219.
55. Seawright, A.A.; Brown, A.W.; Nolan, C.C.; Cavanagh, J.B. Selective degeneration of cerebellar cortical neurons caused by cycad neurotoxin, L-β-methylaminoalanine (L-BMAA), in rats. Neuropathol. Appl. Neurobiol. 1990, 16, 153-169.
56. Shen, W.B.; McDowell, K.A.; Siebert, A.A.; Clark, S.M.; Dugger, N.V.; Valentino, K.M.; Jinnah, H.A.; Sztalryd, C.; Fishman, P.S.; Shaw, C.A.; Jafri, M.S.; Yarowsky, P.J. Environmental neurotoxin-induced progressive model of parkinsonism in rats. Ann. Neurol. 2010, 68, 70-80.
57. Spencer, P.S.; Lasarev, M.R.; Palmer, V.S.; Kisby, G.E. Neurotoxic cycad components and Western Pacific ALS/PDC. Ann. Neurol. 2010, 68, 975-976; author reply 976.
58. Caparros-Lefebvre, D.; Elbaz, A. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: A case-control study. Caribbean Parkinsonism Study Group. Lancet 1999, 354, 281-286.
59. Lannuzel, A.; Hoglinger, G.U.; Champy, P.; Michel, P.P.; Hirsch, E.C.; Ruberg, M. Is atypical parkinsonism in the Caribbean caused by the consumption of Annonacae? J. Neural Transm. Suppl. 2006, 60,153-157.
60. Spencer, P.S.; Ludolph, A.C.; Kisby, G.E. Neurologic diseases associated with use of plant components with toxic potential. Environ.Res. 1993, 62, 106-113.
61. Laqueur, G.L. Carcinogenic effects of cycad meal and cycasin, methylazoxymethanol glycoside, in rats and effects of cycasin in germfree rats. Fed. Proc. 1964, 23, 1386-1388.
62. Moore, M.A.; Baumann, F.; Foliaki, S.; Goodman, M.T.; Haddock, R.; Maraka, R.; Koroivueta, J.; Roder, D.; Vinit, T.; Whippy, H.J.; Sobue, T. Cancer epidemiology in the Pacific islands-past, present and future. Asian Pac. J. Cancer Prev. 2010, S2, 99-106.
63. Borenstein, A.R.; Mortimer, J.A.; Schofield, E.; Wu, Y.; Salmon, D.P.; Gamst, A.; Olichney, J.; Thal, L.J.; Silbert, L.; Kaye, J.; Craig, U.L.; Schellenberg, G.D.; Galasko, D.R. Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam. Neurology 2007, 68, 1764-1771.
64. Shiraki, H.; Yase, Y. Amyotrophic Lateral Sclerosis in Japan. In Handbook of Clinical Neurology Vol 22 System Disorders and Atrophy, Part 2, Vinken, P.J., Bruyn, G.W., Eds.; American Elsevier: New York, NY, USA, 1975; pp. 353-419.
65. Husseman, J.W.; Nochlin, D.; Vincent, I. Mitotic activation: A convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol. Aging 2000, 21, 815-828.
66. Sullivan-Jones, P.; Gouch, A.B.; Holson, R.R. Postnatal methylazoxymethanol: Sensitive periods and regional selectivity of effects. Neurotoxicol. Teratol. 1994, 16, 631-637.
67. Vincent, I.; Pae, C.I.; Hallows, J.L. The cell cycle and human neurodegenerative disease. Prog. Cell Cycle Res. 2003, 5, 31-41.
68. McShea, A.; Lee, H.G.; Petersen, R.B.; Casadesus, G.; Vincent, I.; Linford, N.J.; Funk, J.O.; Shapiro, R.A.; Smith, M.A. Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim. Biophys. Acta 2007, 1772, 467-472.
69. Zhu, X.; Siedlak, S.L.; Wang, Y.; Perry, G.; Castellani, R.J.; Cohen, M.L.; Smith, M.A. Neuronal binucleation in Alzheimer disease hippocampus. Neuropathol. Appl. Neurobiol. 2008, 34, 457-465.
70. Landrigan, P.J.; Sonawane, B.; Butler, R.N.; Trasande, L.; Callan, R.; Droller, D. Early environmental origins of neurodegenerative disease in later life. Environ. Health Perspect 2005, 113, 1230-1233.
71. Plun-Favreau, H.; Lewis, P.A.; Hardy, J.; Martins, L.M.; Wood, N.W. Cancer and neurodegeneration: Between the devil and the deep blue sea. PLoS Genet 2010, 6, e1001257.
72. Morris, L.G.; Veeriah, S.; Chan, T.A. Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene 2010, 29, 3453-3464.
73. Nagata, Y.; Matsumoto, H. Studies on methylazoxymethanol: Methylation of nucleic acids in the fetal rat brain. Proc. Soc. Exp. Biol. Med. 1969, 132, 383-385.
74. Matsumoto, H.; Spatz, M.; Laqueur, G.L. Quantitative changes with age in the DNA content of methylazoxymethanol-induced microencephalic rat brain. J. Neurochem. 1972, 19, 297-306.
75. Kisby, G.E.; Standley, M.; Lu, X.; O'Malley, J.; Lin, B.; Muniz, J.; Luo, N.L.; Pattee, P.; Back, S.A.; Nagalla, S.R. Molecular networks perturbed in a developmental animal model of brain injury. Neurobiol. Dis. 2005, 19, 108-118.
76. Kisby, G.E.; Olivas, A.; Park, T.; Churchwell, M.; Doerge, D.; Samson, L.D.; Gerson, S.L.; Turker, M.S. DNA repair modulates the vulnerability of the developing brain to alkylating agents. DNA Repair 2009, 8, 400-412.
77. Samson, L.D. The repair of DNA alkylation damage by methyltransferases and glycosylases. Essays Biochem. 1992, 27, 69-78.
78. Kleihues, P.; Bucheler, J. Long-term persistence of O6-methylguanine in rat brain DNA. Nature 1977, 269, 625-626.
79. Kreklau, E.L.; Liu, N.; Li, Z.; Cornetta, K.; Erickson, L.C. Comparison of single- versus double-bolus treatments of O(6)-benzylguanine for depletion of O(6)-methylguanine DNA methyltransferase (MGMT) activity in vivo: Development of a novel fluorometric oligonucleotide assay for measurement of MGMT activity. J. Pharmacol. Exp. Ther. 2001, 297, 524-530.
80. Burns, J.A.; Dreij, K.; Cartularo, L.; Scicchitano, D.A. O6-Methylguanine induces altered proteins at the level of transcription in human cells. Nucleic Acids Res. 2010, 38, 8178-8187.
81. 6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors. Proc. Natl. Acad. Sci. USA 1996, 93, 6941-6946.
82. 6-Methylguanine-DNA methyltransferase deficiency in developing brain: Implications for brain tumorigenesis. DNA Repair (Amst.) 2007, 6, 1127-1133.
83. Kisby, G.E.; Standley, M.; Park, T.; Olivas, A.; Fei, S.; Jacob, T.; Reddy, A.; Lu, X.; Pattee, P.; Nagalla, S.R. Proteomic analysis of the genotoxicant methylazoxymethanol (MAM) induced changes in the developing cerebellum. J. Proteome Res. 2006, 5, 2656-2665.
84. Kisby, G.E.; Olivas, A.; Standley, M.; Lu, X.; Pattee, P.; O'Malley, J.; Li, X.; Muniz, J.; Nagalla, R. Genotoxicants target distinct molecular networks in neonatal neurons. Environ. Health. Perspect. 2006, 114, 1703-1712.
85. Yang, W.; Woltjer, R.L.; Sokal, I.; Pan, C.; Wang, Y.; Brodey, M.; Peskind, E.R.; Leverenz, J.B.; Zhang, J.; Perl, D.P.; Galasko, D.R.; Montine, T.J. Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy. Am. J. Pathol. 2007, 171, 993-1002.
86. Coppede, F.; Migliore, L. DNA damage and repair in Alzheimer's disease. Curr. Alzheimer Res. 2009, 6, 36-47.
87. Lovell, M.A.; Markesbery, W.R. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 2007, 35, 7497-7504.
88. Martin, L.J. DNA damage and repair: Relevance to mechanisms of neurodegeneration. J. Neuropathol. Exp. Neurol. 2008, 67, 377-387.
89. Nakabeppu, Y.; Tsuchimoto, D.; Yamaguchi, H.; Sakumi, K. Oxidative damage in nucleic acids and Parkinson's disease. J. Neurosci. Res. 2007, 85, 919-934.
90. Kisby, G.E.; Fry, R.C.; Lasarev, M.R.; Bammler, T.K.; Beyer, R.P.; Churchwell, M.; Doerge, D.R.; Meira, L.B.; Palmer, V.S.; Ramos-Crawford, A.L.; et al. The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damagelinked manner. PLoS One 2011, 6, e20911.
91. Buecheler, J.; Kleihues, P. Excision of O6-methylguanine from DNA of various mouse tissues following a single injection of N-methyl-nitrosourea. Chem. Biol. Interact. 1977, 16, 325-333.
92. Likhachev, A.J.; Alekandrov, V.A.; Anisimov, V.N.; Bespalov, V.G.; Korsakov, M.V.; Ovsyannikov, A.I.; Popovich, I.G.; Napalkov, N.P.; Tomatis, L. Persistence of methylated purines in the DNA of various rat fetal and maternal tissues and carcinogenesis in the offspring following a single transplacental dose of N-methyl-N-nitrosourea. Int. J. Cancer 1983, 31, 779-784.
93. Balduini, W.; Cimino, M.; Lombardelli, G.; Abbracchio, M.P.; Peruzzi, G.; Cecchini, T.; Gazzanelli, G.C.; Cattabeni, F. Microencephalic rats as a model for cognitive disorders. Clin. Neuropharmacol. 1986, 9, S8-S18.
94. Cattabeni, F.; Di Luca, M. Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol. Physiol. Rev. 1997, 77, 199-215.
95. Laqueur, G.L. Carcinogenic effects of cycad meal and cycasin, methylazoxymethanol glycoside, in rats and effects of cycasin in germfree rats. Fed. Proc. 1964, 23, 1386-1388.
96. Nigro, N.D. Animal model for colorectal cancer. Prog. Clin. Biol. Res. 1985, 186, 161-173.
97. Garruto, R.M.; Gadjusek, D.C.; Chen, K.-M. Amyotrophic lateral sclerosis among Chamorro migrants from Guam. Ann. Neurol. 1980, 8, 612-619.
98. Garruto, R.M.; Gadjusek, D.C.; Chen, K.-M. Amyotrophic lateral sclerosis and parkinsonism-dementia among Filipino migrants to Guam. Ann. Neurol. 1981, 10, 341-350.
99. Anderson, F.H.; Richardson, E.P.; Okazaki, H.; Brody, J.A. Neurofibrillary degeneration on Guam: Frequency in Chamorros and non Chamorros with no known neurological disease. Brain 1979, 102, 65-77.
100. Kisby, G.E.; Palmer, V.S.; Lasarev, M.R.; Fry, R.; Iordanov, M.; Magun, E.; Samson, L.; Spencer, P. Does the cycad genotoxin MAM implicated in Guam ALS-PDC induce disease-relevant changes in mouse brain that includes olfaction? Commun. Integr. Biol., In press.
101. Doty, R.L.; Perl, D.P.; Steele, J.C.; Chen, K.M.; Pierce, J.D., Jr.; Reyes, P.; Kurland, L.T. Odor identification deficit of the Parkinsonism-dementia complex of Guam: Equivalence to that of Alzheimer's and idiopathic Parkinson's disease. Neurology 1991, 41, 77-80.
102. Ahlskog, J.E.; Waring, S.C.; Petersen, R.C.; Esteban-Santillan, C.; Craig, U.K.; O'Brien, P.C.; Plevak, M.F.; Kurland, L.T. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology 1998, 51, 1672-1677.
103. Wilson, R.S.; Arnold, S.E.; Schneider, J.A.; Boyle, P.A.; Buchman, A.S.; Bennett, D.A. Olfactory impairment in presymptomatic Alzheimer's disease. Ann. N. Y. Acad. Sci. 2009, 1170, 730-735.
104. Berendse, H.W.; Roos, D.S.; Raijmakers, P.; Doty, R.L. Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease. J. Neurol. Sci. doi:10.1016/j.jns.2011.06.020. Published online: 24 June 2011.
105. Doty, R.L.; Perl, D.P.; Steele, J.C.; Chen, K.M.; Pierce, J.D., Jr.; Reyes, P.; Kurland, L.T. Olfactory dysfunction in three neurodegenerative diseases. Geriatrics 1991, 46S, 47-51.
106. Staropoli, J.F. Tumorigenesis and neurodegeneration: Two sides of the same coin? Bioessays 2008, 30, 719-727.
107. Caricasole, A.; Bakker, A.; Copani, A.; Nicoletti, F.; Gaviraghi, G.; Terstappen, G.C. Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. Biosci. Rep. 2005, 25, 309-327.
108. Muyllaert, D.; Kremer, A.; Jaworski, T.; Borghgraef, P.; Devijver, H.; Croes, S.; Dewachter, I.; van Leuven, F. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology? Genes Brain Behav. 2008, 7S, 57-66.
109. Behrens, M.I.; Lendon, C.; Roe, C.M. A common biological mechanism in cancer and Alzheimer's disease? Curr. Alzheimer Res. 2009, 6, 196-204.
110. Souter, S.; Lee, G. Tubulin-independent tau in Alzheimer's disease and cancer: Implications for disease pathogenesis and treatment. Curr. Alzheimer Res. 2010, 7, 697-707.
111. Serrano, J.; Fernandez, A.P.; Martinez-Murillo, R.; Martinez, A. High sensitivity to carcinogens in the brain of a mouse model of Alzheimer's disease. Oncogene, 2010, 29, 2165-2171.
112. Chen, J.; Huang, X.F. The signal pathways in azoxymethane-induced colon cancer and preventive implications. Cancer Biol. Ther. 2009, 8, 1313-1317.
113. Wali, R.K.; Skarosi, S.; Hart, J.; Zhang, Y.; Dolan, M.E.; Moschel, R.C.; Nguyen, L.; Mustafi, R.; Brasitus, T.A.; Bissonnette, M. Inhibition of O(6)-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats. Carcinogenesis 1999, 20, 2355-2360.
114. Takahashi, M.; Nakatsugi, S.; Sugimura, T.; Wakabayashi, K. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis 2000, 21, 1117-1120.
115. Bonfanti, M.; Broggini, M.; Prontera, C.; D'Incalci, M. O6-Methylguanine inhibits the binding of transcription factors to DNA. Nucleic Acids Res. 1991, 19, 5739-5742.
116. Ghosh, R.; Mitchell, D.L. Effect of oxidative DNA damage in promoter elements on transcription factor binding. Nucleic Acids Res. 1999, 27, 3213-3218.
117. Parsian, A.J.; Funk, M.C.; Tao, T.Y.; Hunt, C.R. The effect of DNA damage on the formation of protein/DNA complexes. Mutat. Res. 2002, 501, 105-113.
118. Hailer-Morrison, M.K.; Kotler, J.M.; Martin, B.D.; Sugden, K.D. Oxidized guanine lesions as modulators of gene transcription. Altered p50 binding affinity and repair shielding by 7,8-dihydro-8-oxo-2'-deoxyguanosine lesions in the NF-kappaB promoter element. Biochemistry 2003, 42, 9761-9770.
119. Yamini, B.; Yu, X.; Dolan, M.E.; Wu, M.H.; Kufe, D.W.; Weichselbaum, R.R. Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding. Cancer Res. 2007, 67, 6889-6898.
120. Bregeon, D.; Peignon, P.A.; Sarasin, A. Transcriptional mutagenesis induced by 8 oxoguanine in mammalian cells. PLoS Genet. 2009, 5, e1000577.
121. Bregeon, D.; Doetsch, P.W. Transcriptional mutagenesis: Causes and involvement in tumour development. Nat. Rev. Cancer 2011, 11, 218-227.
122. de la Monte, S.M.; Neusner, A.; Chu, J.; Lawton, M. Epidemiological trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis. J. Alzheimers Dis. 2009, 17, 519-529.
123. McCutcheon, J.W. Nitrosamines in bacon: A case study of balancing risks. Public Health Rep. 1984, 99, 360-364.
124. Liu, C.; Russell, R.M. Nutrition and gastric cancer risk: An update. Nutr. Rev. 2008, 66, 237-249.
125. Lijinsky, W. N-Nitroso compounds in the diet. Mutat. Res. 1999, 443, 129-138.
126. Le Roux, J.; Gallard, H.; Croue, J.P. Chloramination of nitrogenous contaminants (pharmaceuticals and pesticides): NDMA and halogenated DBPs formation. Water Res.2011, 45, 3164-3174.
127. Oury, B.; Limasset, J.C.; Protois, J.C. Assessment of exposure to carcinogenic N-nitrosamines in the rubber industry. Int. Arch. Occup. Environ. Health 1997, 70, 261-271.
128. Bolzan, A.D.; Bianchi, M.S. Genotoxicity of streptozotocin. Mutat. Res. 2002, 512, 121-134.
129. Ahles, T.A.; Saykin, A.J. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat. Rev. Cancer 2007, 7, 192-201.
130. Wefel, J.S.; Kayl, A.E.; Meyers, C.A. Neuropsychological dysfunction associated with cancer and cancer therapies: A conceptual review of an emerging target. Br. J. Cancer 2004, 90, 1691-1696.
131. Thomson, M.A.; Green, C.R.; Rasma, B.B.; Holtshouser, J.L.; Hinderer, R.K.; Papciak, R.J.; Leung, H.; Howe, S.R.; Kuhn, T.D. N-Nitrosamines in Patty's Industrial Hygiene and Toxicology, 4th ed.; Clayton, G.D., Clayton, F.E., Eds.; John Wiley & Sons, Etobicoke, ON, Canada, 1993; Chapter 11, pp. 665-668.
132. Salkovic-Petrisic, M.; Hoyer, S. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: An experimental approach. J. Neural Transm. Suppl. 2007, 72, 217-233.
133. de la Monte, S.M.; Tong, M. Mechanisms of nitrosamine-mediated neurodegeneration: Potential relevance to sporadic Alzheimer's disease. J. Alzheimers Dis. 2009, 17, 817-825.
134. Agrawal, R.; Tyagi, E.; Shukla, R.; Nath, C. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology 2009, 56, 779-787.
135. Clodfelder-Miller, B.J.; Zmijewska, A.A.; Johnson, G.V.; Jope, R.S. Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes 2006, 55, 3320-3325.
136. Ke, Y.D.; Delerue, F.; Gladbach, A.; Gotz, J.; Ittner, L.M. Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PLoS One 2009, 4, e7917.
137. Salkovic-Petrisic, M.; Tribl, F.; Schmidt, M.; Hoyer, S.; Riederer, P. Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J. Neurochem. 2006, 96, 1005-1015.
138. Tong, M.; Longato, L.; de la Monte, S.M. Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration. BMC Endocr. Disord. 2010, 10, 4.
139. Kihira, T.; Suzuki, A.; Kondo, T.; Wakayama, I.; Yoshida, S.; Hasegawa, K.; Garruto, R.M. Immunohistochemical expression of IGF-I and GSK in the spinal cord of Kii and Guamanian ALS patients. Neuropathology 2009, 29, 548-558.
140. Craft, S. Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment. Curr. Alzheimer Res. 2007, 4, 147-152.
141. Eikelenboom, P.; van Exel, E.; Hoozemans, J.J.; Veerhuis, R.; Rozemuller, A.J.; van Gool, W.A. Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer's disease. Neurodegen. Dis. 2010, 7, 38-41.
142. Gallo, V.; Bueno-De-Mesquita, H.B.; Vermeulen, R.; Andersen, P.M.; Kyrozis, A.; Linseisen, J.; Kaaks, R.; Allen, N.E.; Roddam, A.W.; Boshuizen, H.C.; et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann. Neurol. 2009, 65, 378-385.
143. Weisskopf, M.G.; Morozova, N.; O'Reilly, E.J.; McCullough, M.L.; Calle, E.E.; Thun, M.J.; Ascherio, A. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J. Neurol. Neurosur. Ps. 2009, 80, 558-561.
144. Esclaire, F.; Kisby, G.E.; Milne, J.; Lesort, M.; Spencer, P.; Hugon, J. The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity. Exp. Neurol. 1999, 155, 11-21.
145. Hugon, J.; Esclaire, F.; Lesort, M.; Kisby, G.; Spencer, P. Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions. Drug Metab. Rev. 1999, 31, 635-647.
146. Murch, S.J.; Cox, P.A.; Banack, S.A. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc. Natl. Acad. Sci. USA 2004, 101, 12228-12231.
147. Prusiner, S.B.; DeArmond, S.J. Molecular biology and pathology of scrapie and the prion diseases of humans. Brain Pathol. 1991, 1, 297-310.
148. Sikorska, B.; Liberski, P.P.; Sobow, T.; Budka, H.; Ironside, J.W. Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: A comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease. Neuropathol. Appl. Neurobiol. 2009, 35, 46-59.